Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Cash from Operations (2022 - 2026)

Core Laboratories filings provide 5 years of Cash from Operations readings, the most recent being 3965000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 40.47% to 3965000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 34336000.0, a 40.3% decrease, with the full-year FY2025 number at 37031000.0, down 34.33% from a year prior.
  • Cash from Operations hit 3965000.0 in Q1 2026 for Core Laboratories, down from 7946000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 20615000.0 in Q4 2024 to a low of 3169000.0 in Q1 2023.
  • Median Cash from Operations over the past 5 years was 8502000.0 (2025), compared with a mean of 9415600.0.
  • Biggest five-year swings in Cash from Operations: plummeted 103.62% in 2023 and later skyrocketed 6277.83% in 2024.
  • Core Laboratories' Cash from Operations stood at 13211000.0 in 2022, then surged by 47.07% to 19429000.0 in 2023, then grew by 6.1% to 20615000.0 in 2024, then crashed by 61.46% to 7946000.0 in 2025, then plummeted by 50.1% to 3965000.0 in 2026.
  • The last three reported values for Cash from Operations were 3965000.0 (Q1 2026), 7946000.0 (Q4 2025), and 8502000.0 (Q3 2025) per Business Quant data.